New Key Statistics Module, Z-Score and F-Score
HKSE:02607 Key Ratios
| Market Cap HK$ M | 62,725.28 |
| Enterprise Value HK$ M | 88,449.48 |
| P/E(ttm) | 7.53 |
| PE Ratio without NRI | 6.65 |
| Forward PE Ratio | 6.13 |
| Price/Book | 0.77 |
| Price/Sales | 0.21 |
| Price/Free Cash Flow | 8.06 |
| Price/Owner Earnings | 23.59 |
| Payout Ratio % | 0.27 |
| Revenue (TTM) HK$ M | 324,974.00 |
| EPS (TTM) HK$ | 1.47 |
| Beneish M-Score | -2.56 |
| 10-y EBITDA Growth Rate % | 5.70 |
| 5-y EBITDA Growth Rate % | -2.10 |
| y-y EBITDA Growth Rate % | -14.20 |
| EV-to-EBIT | 7.74 |
| EV-to-EBITDA | 7.74 |
| PEG | -- |
| Shares Outstanding M | 3,708.36 |
| Net Margin (%) | 1.65 |
| Operating Margin % | 3.49 |
| Pre-tax Margin (%) | 2.98 |
| Quick Ratio | 1.04 |
| Current Ratio | 1.34 |
| ROA % (ttm) | 2.01 |
| ROE % (ttm) | 6.24 |
| ROIC % (ttm) | 6.73 |
| Dividend Yield % | 4.82 |
| Altman Z-Score | 2.05 |
HKSE:02607 Number of Guru Trades
HKSE:02607 Volume of Guru Trades
Gurus Latest Trades with HKSE:02607
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
HKSE:02607 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shanghai Pharmaceuticals Holding Co Ltd Insider Transactions
No Available Data